Tobacco use

Z21_TOBAC_USE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z72.0 Cause of death: ICD-10 — Z72.0 2 out of 7 registries used, show all original rules.	1971
4. Check minimum number of events None	1971
5. Include endpoints None	1971
6. Filter based on genotype QC (FinnGen only)	1971

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
Special: TOBACCO_USE
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z72

NAME	Z21_TOBAC_USE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z720
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z720
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Tobacco use based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15107	8245	6808
Only index persons	14765	8149	6616
Unadjusted period prevalence (%)
Whole population	0.21	0.24	0.19
Only index persons	0.28	0.30	0.25
Median age at first event (years)
Whole population	47.75	38.80	58.70
Only index persons	47.47	38.45	58.59

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1971	1053	918
Unadjusted period prevalence (%)	0.38	0.36	0.40
Median age at first event (years)	52.06	46.19	58.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1730: Matched controls
17301

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z72.0

ICD-10 Finland

Tobacco use

+∞

323.0

1730

107

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

8.7

180.7

429

632

N07BA03

ATC

varenicline; oral

10.6

172.5

358

414

R03BB04

ATC

tiotropium bromide; inhalant

5.8

111.7

351

725

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

9.0

88.5

197

244

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.9

73.9

177

245

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

10.2

69.4

142

150

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.6

68.4

258

630

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.9

65.2

229

518

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

64.4

832

4791

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

10.7

60.8

121

EBA00

NOMESCO Finland

Extraction of tooth

2.4

60.4

723

3964

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

54.6

470

2127

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.0

53.4

183

400

K05.31

ICD-10 Finland

Periodontitis pronounced

3.7

53.1

261

802

N02AX02

ATC

tramadol; systemic, rectal

2.2

53.0

812

4918

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.5

52.4

142

233

R03AC02

ATC

salbutamol; inhalant

2.2

51.1

990

6622

N05AH04

ATC

quetiapine; oral

2.7

50.8

404

1735

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.7

49.7

243

741

H02AB06

ATC

prednisolone; systemic

2.1

49.6

868

5523

B01AC04

ATC

clopidogrel; oral

3.1

48.4

308

1144

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.0

48.2

321

1227

AA1AD

NOMESCO Finland

CT of head and brain

2.5

47.7

453

2141

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

4.6

46.1

170

400

N06AX11

ATC

mirtazapine; oral

2.2

45.7

615

3441

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

45.7

403

1825

N06AB04

ATC

citalopram; systemic

2.4

45.2

462

2259

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.1

44.9

280

1021

P17

ICPC

Tobacco abuse

10.6

44.5

EBA15

NOMESCO Finland

Extraction of large number of teeth

5.5

44.2

137

266

N05BA04

ATC

oxazepam; oral

2.3

43.3

493

2538

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

43.2

321

1310

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

42.8

374

1676

SPAT1254

SPAT

Administration of medicine

2.8

42.6

307

1226

SPAT1263

SPAT

Sampling

2.0

42.5

817

5282

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

42.2

256

912

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.0

42.0

141

300

P01AB01

ATC

metronidazole; oral, rectal

2.1

41.5

734

4570

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.8

40.5

302

1228

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.6

39.8

193

581

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

39.5

364

1672

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.7

39.2

181

523

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

8.2

39.1

113

N03AX16

ATC

pregabalin; oral

2.3

38.7

454

2349

C03CA01

ATC

furosemide; systemic

2.3

38.6

424

2126

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

38.4

277

1100

N07BB01

ATC

disulfiram; oral

4.1

38.0

159

421

N02BE01

ATC

paracetamol; systemic, rectal

2.4

38.0

1495

12601

N03AX12

ATC

gabapentin; oral

2.6

37.0

311

1351

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

36.4

778

5133

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

36.3

36.0

C10AA05

ATC

atorvastatin; oral

2.0

35.8

617

3745

Z72.1

ICD-10 Finland

Alcohol use

8.9

35.0

N06AX16

ATC

venlafaxine; oral

2.5

35.0

313

1405

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

33.9

211

759

C07AB07

ATC

bisoprolol; oral

1.9

33.7

737

4858

SPAT1301

SPAT

No procedures

2.0

32.4

576

3504

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.9

31.9

208

770

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

31.8

865

6110

N05CF01

ATC

zopiclone; oral

2.0

31.4

537

3211

J01FF01

ATC

clindamycin; systemic

2.0

31.3

527

3130

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

31.3

574

3524

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

30.9

447

2500

R95

ICPC

Chron obstructive pulmonary disease

5.8

30.8

159

K08.3

ICD-10 Finland

Retained dental root

3.3

30.3

163

529

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

29.8

206

793

R06.0

ICD-10 Finland

Dyspnoea

2.1

29.7

425

2358

M54.5

ICD-10 Finland

Low back pain

1.9

29.6

604

3838

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.5

29.5

124

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.0

29.4

481

2812

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

29.2

486

2860

N06AB10

ATC

escitalopram; oral

2.1

28.8

412

2283

Z72.2

ICD-10 Finland

Drug use

21.5

28.8

ZXD05

NOMESCO Finland

Urgent procedure

1.9

28.7

583

3689

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

28.4

172

606

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

28.3

312

1541

SPAT1240

SPAT

Therapeutic discussion

2.5

27.3

245

1091

SPAT1310

SPAT

Counselling related to known health issue

1.8

27.2

577

3687

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.1

27.1

336

1746

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

26.7

721

4983

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.8

26.7

187

724

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.0

26.6

383

2116

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.6

26.5

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

26.5

393

2201

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

26.3

422

2436

N05AA02

ATC

levomepromazine; systemic

3.8

26.2

115

317

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

26.2

438

2567

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.5

26.2

149

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

26.1

204

843

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.7

26.0

A02BC02

ATC

pantoprazole; systemic

1.7

25.9

1061

8281

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

25.9

279

1358

SPAT1262

SPAT

Handing over of treatment supplies

2.1

25.5

329

1733

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.5

25.1

210

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.3

24.9

154

N02AA05

ATC

oxycodone; systemic

2.3

24.8

246

1149

R02

ICPC

Shortness of breath/dyspnoea

2.4

24.5

225

1011

J01AA02

ATC

doxycycline; systemic

1.8

24.5

1300

10879

SPAT1312

SPAT

General health counselling

1.8

24.4

579

3807

A10BA02

ATC

metformin; oral

1.9

24.3

441

2650

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

24.3

361

2015

S18

ICPC

Laceration/cut

1.7

24.1

680

4716

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

23.7

171

673

M79.6

ICD-10 Finland

Pain in limb

1.8

23.4

585

3900

J01DB01

ATC

cefalexin; oral

1.9

23.3

1417

12257

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

23.3

805

5905

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

22.9

326

1782

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

22.9

611

4149

SPAT1260

SPAT

Consultation of another employee

2.0

22.8

320

1741

N05AH03

ATC

olanzapine; systemic

2.9

22.6

145

530

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

22.3

542

3571

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

22.3

155

596

WX110

NOMESCO Finland

Local anesthesy

1.7

22.2

1202

9929

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.5

22.0

124

WX290

NOMESCO Finland

Other blockade of nerve

1.7

22.0

815

6062

A46

ICD-10 Finland

Erysipelas

2.2

21.9

236

1143

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

7.9

21.8

L03

ICPC

Low back symptom/complaint

1.8

21.8

421

2572

N06AB06

ATC

sertraline; oral

2.3

21.7

221

1042

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

21.6

572

3859

P15

ICPC

Chronic alcohol abuse

4.0

21.6

228

W84

ICPC

Pregnancy high risk

3.7

21.5

274

S10

ICPC

Boil/carbuncle

3.0

21.3

127

442

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

21.3

172

722

SPAT1283

SPAT

Restricted health certificate

1.9

21.1

366

2151

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.5

21.1

101

300

N05CD07

ATC

temazepam; oral

2.4

20.8

196

890

N06AB03

ATC

fluoxetine; oral

2.2

20.8

233

1147

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.4

20.7

104

321

SPAT1104

SPAT

Monitoring of emergency patient

2.9

20.6

133

488

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.5

20.6

167

701

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

20.5

101

307

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

20.5

163

675

A10AE04

ATC

insulin glargine; parenteral

2.4

20.5

187

837

J01DA01

ATC

[U] cefalexin; systemic

1.6

20.4

1056

8502

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

20.4

103

319

J01FA06

ATC

roxithromycin; oral

1.6

20.3

669

4785

T90

ICPC

Diabetes non-insulin dependent

1.9

20.2

357

2106

C09AA05

ATC

ramipril; oral

1.9

20.1

364

2168

R51.80

ICD-10 Finland

Headache

2.0

19.9

278

1502

P76

ICPC

Depressive disorder

2.7

19.9

140

541

N06AX12

ATC

bupropion; oral

2.7

19.9

144

567

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.7

19.8

140

544

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.4

19.8

179

796

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

19.8

450

2885

N03AG01

ATC

valproic acid; systemic, rectal

2.7

19.7

140

546

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

19.7

117

406

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

7.3

19.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

19.5

321

1847

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.5

19.4

282

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

19.3

641

4576

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

15.8

19.3

S97

ICPC

Chronic ulcer skin

3.3

19.2

312

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.1

19.1

188

WZA90

NOMESCO Finland

Other doctors statement

1.8

19.1

409

2568

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.1

19.1

246

1284

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.9

19.1

133

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

11.5

19.0

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

18.9

274

1498

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.3

18.9

113

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

18.8

228

1163

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

18.7

225

1140

J01MA14

ATC

moxifloxacin; systemic

2.4

18.7

165

725

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

18.7

452

2942

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.6

18.7

144

588

Z2446

NOMESCO Finland

Social worker

2.7

18.7

131

507

L28

ICPC

Limited function/disability (L)

2.1

18.7

225

1143

N05BA01

ATC

diazepam; systemic, rectal

2.1

18.6

235

1218

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

18.5

184

856

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

18.4

215

1078

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

18.4

131

510

C08CA01

ATC

amlodipine; oral

1.7

18.3

499

3360

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

18.3

141

574

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

18.3

177

813

J43.9

ICD-10 Finland

Emphysema, unspecified

7.0

18.3

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

18.2

294

1674

E66.00

ICD-10 Finland

Metabolic syndrome

2.9

18.2

116

423

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.9

18.1

E66.9

ICD-10 Finland

Obesity, unspecified

3.4

18.1

276

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

18.0

117

429

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

18.0

256

1392

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

8.8

17.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

17.9

162

720

N05AX08

ATC

risperidone; systemic

2.5

17.8

141

583

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.6

17.7

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

7.6

17.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

17.6

1199

10141

A28

ICPC

Limited function/disability NOS

2.2

17.5

189

914

P29

ICPC

Psychological sympt/compl other

2.7

17.5

124

483

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.7

17.3

129

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

17.3

936

7475

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.9

17.3

N05BA02

ATC

chlordiazepoxide; systemic

4.0

17.3

181

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

17.1

179

850

C10AA01

ATC

simvastatin; oral

1.6

17.0

587

4198

J20

ICD-10 Finland

Acute bronchitis

2.2

17.0

176

834

R03DA04

ATC

theophylline; systemic, rectal

3.3

17.0

273

L17

ICPC

Foot/toe symptom/complaint

1.7

17.0

386

2459

SPAT1211

SPAT

Application of soft bandage

2.3

16.9

159

720

EBA30

NOMESCO Finland

Excision of root of tooth

2.8

16.9

112

419

J96.1

ICD-10 Finland

Chronic respiratory failure

5.5

16.7

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

15.2

16.7

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

16.6

330

2014

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

16.5

127

517

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

16.4

229

1231

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

16.4

145

637

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

16.4

188

934

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

6.7

16.4

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

16.3

111

420

J46

ICD-10 Finland

Status asthmaticus

4.3

16.2

143

A05

ICPC

Feeling ill

2.6

16.2

118

466

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

15.9

133

567

Z32.1

ICD-10 Finland

Pregnancy confirmed

2.1

15.8

190

961

R96

ICPC

Asthma

2.3

15.8

153

703

J45.8

ICD-10 Finland

Mixed asthma

3.7

15.7

187

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

15.7

442

2983

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

15.6

853

6760

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

15.5

260

1493

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

8.2

15.5

N06AX21

ATC

duloxetine; oral

2.1

15.5

190

968

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

15.5

821

6455

K02.1

ICD-10 Finland

Caries of dentine

1.5

15.4

981

8031

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.2

15.4

255

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

15.3

165

796

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

15.3

397

2615

A06AD11

ATC

lactulose; oral

2.0

15.2

200

1048

R03AC03

ATC

terbutaline; inhalant

1.9

15.1

234

1307

N05BA12

ATC

alprazolam; oral

2.1

15.1

181

914

R05

ICPC

Cough

1.7

15.1

366

2364

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.9

15.1

B01AB05

ATC

enoxaparin; parenteral

1.6

15.0

451

3089

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

15.0

205

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

14.9

104

402

J45

ICD-10 Finland

Asthma

2.1

14.9

168

827

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

14.8

161

780

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.0

14.8

308

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.5

14.8

A07AA02

ATC

nystatin; oral

2.8

14.8

373

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

14.7

219

1205

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

14.6

643

4831

SPAT1058

SPAT

PEF monitoring instruction

2.2

14.5

147

687

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.1

14.5

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

14.4

161

789

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

4.2

14.4

131

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

14.4

1189

10228

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

14.3

167

835

N05AX12

ATC

aripiprazole; systemic

2.9

14.2

322

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.9

14.2

316

J01MA12

ATC

levofloxacin; systemic

1.8

14.2

295

1817

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.5

14.1

118

501

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.8

14.1

163

R06.2

ICD-10 Finland

Wheezing

2.8

14.1

335

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

14.1

194

1038

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

14.1

207

1134

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

3.5

14.0

195

SPAT1255

SPAT

Intravenous administration of medicine

2.5

14.0

115

486

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.9

13.9

301

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.4

13.8

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.9

13.8

G47.3

ICD-10 Finland

Sleep apnoea

1.7

13.7

360

2371

A01

ICPC

Pain general/multiple sites

2.4

13.7

121

529

N05BE01

ATC

buspirone; oral

3.3

13.7

210

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.1

13.5

N05AB01

ATC

dixyrazine; systemic

5.1

13.5

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.9

13.5

289

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.4

13.5

111

N05AF03

ATC

chlorprothixene; systemic

3.3

13.5

207

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

13.4

323

2073

M79.7

ICD-10 Finland

Fibromyalgia

3.3

13.4

214

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.3

13.3

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

13.3

390

P74

ICPC

Anxiety disorder/anxiety state

2.9

13.3

277

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

2.5

13.3

110

466

SPAT1059

SPAT

Spirometry at the office

2.5

13.3

102

417

SPAT1216

SPAT

Assessment of functional ability

1.9

13.3

210

1180

F10.24

ICD-10 Finland

Alcohol depence active use

4.8

13.2

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

13.1

160

813

C01DA14

ATC

isosorbide mononitrate; oral

2.0

13.1

174

916

WX722

NOMESCO Finland

PEEP

2.6

13.1

364

L73.2

ICD-10 Finland

Hidradenitis suppurativa

5.3

13.0

PE1AT

NOMESCO Finland

Femoral artery PTA

8.4

13.0

SPAT1153

SPAT

Removal of sutures

1.6

13.0

475

3393

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.1

13.0

241

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.8

13.0

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

3.3

12.9

198

PEN23

NOMESCO Finland

Plastic repair of femoral artery

7.7

12.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

12.9

312

2004

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

12.9

119

535

SPAT1360

SPAT

Extensive global examination

2.3

12.9

122

556

N03AE01

ATC

clonazepam; systemic

2.5

12.8

101

417

J01CA04

ATC

amoxicillin; systemic

1.5

12.8

1347

12027

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

12.8

221

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

12.8

314

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.3

12.8

R50.9

ICD-10 Finland

Fever, unspecified

1.8

12.7

223

1296

T89

ICPC

Diabetes insulin dependent

2.7

12.7

332

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.6

12.7

R52.0

ICD-10 Finland

Acute pain

3.0

12.7

243

R03AK08

ATC

formoterol and beclometasone; inhalant

2.9

12.6

273

P01

ICPC

Feeling anxious/nervous/tense

1.9

12.6

186

1020

V03AA01

ATC

4.0

12.6

124

R60.0

ICD-10 Finland

Localized oedema

2.0

12.6

160

828

O80.9

ICD-10 Finland

Single spontaneous delivery, unspecified

5.5

12.6

M48.0

ICD-10 Finland

Spinal stenosis

2.0

12.6

158

814

R42

ICD-10 Finland

Dizziness and giddiness

1.7

12.6

294

1872

XPX08

NOMESCO Finland

Intraoperative flow measurement

8.3

12.5

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

12.5

286

1805

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.9

12.5

265

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

12.5

171

SPAT1097

SPAT

Recording of ECG

1.8

12.4

217

1260

P03

ICPC

Feeling depressed

2.0

12.4

171

911

N03AX09

ATC

lamotrigine; oral

2.5

12.3

101

426

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.9

12.3

127

A03

ICPC

Fever

1.7

12.3

273

1713

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

12.3

297

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

9.7

12.2

L12

ICPC

Hand/finger symptom/complaint

1.8

12.2

220

1290

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

12.2

138

681

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.0

12.2

155

802

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.7

12.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.6

12.1

331

A02BC03

ATC

lansoprazole; oral

1.6

12.1

418

2944

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

12.1

362

2460

F61.0

ICD-10 Finland

Mixed personality disorders

4.0

12.1

124

R03AC18

ATC

indacaterol; inhalant

10.1

12.0

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.4

11.9

177

H02AB04

ATC

methylprednisolone; systemic

1.8

11.9

223

1326

Z3231

NOMESCO Finland

Registered nurse

1.5

11.9

414

2921

A29

ICPC

General symptom/complaint other

2.0

11.9

165

885

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.0

11.8

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

11.8

342

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.5

11.8

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.7

11.8

T74.1

ICD-10 Finland

Physical abuse

3.7

11.8

142

R53

ICD-10 Finland

Malaise and fatigue

1.6

11.8

300

1952

C10AX09

ATC

ezetimibe; oral

1.9

11.7

164

882

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

11.7

271

S04

ICPC

Lump/swelling localized

2.0

11.7

150

780

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

11.7

200

1152

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

16.5

11.7

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

6.9

11.6

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

11.6

282

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.6

11.6

350

E66.8

ICD-10 Finland

Other obesity

2.3

11.6

105

467

SPAT1057

SPAT

Peak expiratory flow measurement

3.5

11.5

150

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

11.5

285

A04

ICPC

Weakness/tiredness general

1.8

11.5

190

1083

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

11.4

211

N05AB03

ATC

perphenazine; systemic, rectal

2.7

11.4

287

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.0

11.4

111

R03BA01

ATC

beclometasone; inhalant

1.8

11.4

213

1264

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.2

11.3

121

582

F92.0

ICD-10 Finland

Depressive conduct disorder

11.9

11.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

11.3

185

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

11.3

174

970

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

10.6

11.3

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

6.3

11.2

R04.2

ICD-10 Finland

Haemoptysis

3.0

11.2

218

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.0

11.2

225

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.7

11.2

133

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.5

11.2

149

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.3

11.1

103

465

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.5

11.1

144

348

Kela drug reimbursment

Roflumilast

20.2

11.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.0

11.0

110

K04.0

ICD-10 Finland

Pulpitis

1.8

11.0

184

1053

R03BA05

ATC

fluticasone; inhalant

1.6

11.0

279

1813

WX892

NOMESCO Finland

Monitored bed care

2.1

11.0

127

631

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

11.0

422

L05

ICPC

Flank/axilla symptom/complaint

2.4

10.9

394

N05AH02

ATC

clozapine; systemic

3.6

10.9

136

P19

ICPC

Drug abuse

6.0

10.9

P99

ICPC

Psychological disorders other

3.1

10.9

196

R52.2

ICD-10 Finland

Other chronic pain

3.0

10.9

211

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.5

10.9

SPAT1357

SPAT

Monitoring of problem during pregnancy

3.0

10.9

202

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

10.9

228

1401

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

10.8

418

3009

R03AC13

ATC

formoterol; inhalant

2.6

10.8

322

A08

ICPC

Swelling

2.9

10.8

220

D10

ICPC

Vomiting

2.2

10.8

112

533

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

10.7

420

WZC30

NOMESCO Finland

Teaching

1.8

10.7

207

1241

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.5

10.6

139

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

10.6

228

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

10.6

177

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

10.6

260

1669

M79.1

ICD-10 Finland

Myalgia

1.8

10.6

201

1197

H02AB07

ATC

prednisone; oral

1.8

10.6

206

1237

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

10.5

422

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

9.2

10.5

F41.00

ICD-10 Finland

Moderate panic disorder

3.9

10.5

110

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

10.4

100

460

F43.0

ICD-10 Finland

Acute stress reaction

2.5

10.4

336

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

10.4

401

2885

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

10.3

175

1006

S76

ICPC

Skin infection other

2.4

10.3

349

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

10.3

133

692

TQW80

NOMESCO Finland

Local dermatologic skincare

3.3

10.3

154

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.3

10.3

154

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.3

10.3

402

R03DX07

ATC

roflumilast; oral

18.9

10.3

PD3AT

NOMESCO Finland

Pelvic artery PTA

9.6

10.3

K05.30

ICD-10 Finland

Periodontitis complex

1.8

10.2

186

1097

N05AN01

ATC

lithium; oral

3.0

10.1

199

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

10.1

264

1723

N06AA12

ATC

doxepin; systemic

2.4

10.1

359

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

10.1

544

4188

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

11.4

10.1

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

8.5

10.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

10.0

147

804

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

10.1

10.0

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.2

10.0

163

L86

ICPC

Back syndrome with radiating pain

2.3

9.9

396

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

9.9

137

F32

ICD-10 Finland

Depressive episode

2.2

9.8

444

A01AB09

ATC

miconazole; local oral

2.0

9.8

123

634

SPAT1234

SPAT

Support of social functional capacity

2.5

9.8

295

K04.08

ICD-10 Finland

Other specified pulpit

2.0

9.8

123

635

SPAT1251

SPAT

Organisation of medication

2.9

9.8

199

M03BX02

ATC

tizanidine; oral

1.4

9.7

997

8577

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

6.2

9.7

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.2

9.7

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

9.7

340

2389

SPAT1274

SPAT

Brief intervention in person with addiction symptoms

13.4

9.7

-1

NOMESCO Finland

1.4

9.6

541

4186

WX872

NOMESCO Finland

Intensive care

2.3

9.6

389

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

9.6

615

4872

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.7

9.6

249

R03BA02

ATC

budesonide; inhalant

1.6

9.6

260

1715

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

8.4

9.6

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.6

9.5

120

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

9.5

121

627

Z50.1

ICD-10 Finland

Other physical therapy

2.3

9.5

384

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

9.5

193

1172

M25.5

ICD-10 Finland

Pain in joint

1.5

9.5

428

3171

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

9.5

206

1278

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

9.5

164

950

I25.2

ICD-10 Finland

Old myocardial infarction

2.2

9.5

419

S22.3

ICD-10 Finland

Fracture of rib

2.1

9.4

105

515

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.9

9.4

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

17.6

9.4

SBA00

NOMESCO Finland

Microbiological examinations

3.4

9.4

127

R63.4

ICD-10 Finland

Abnormal weight loss

2.9

9.4

200

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

9.3

310

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

9.3

414

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

9.3

203

1262

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

9.3

350

R11

ICD-10 Finland

Nausea and vomiting

2.0

9.3

119

617

C07AA05

ATC

propranolol; systemic

1.6

9.3

296

2031

J96.9

ICD-10 Finland

Respiratory failure, unspecified

10.7

9.3

R4110

NOMESCO Finland

Physiotherapy

1.5

9.3

379

2750

RS221

NOMESCO Finland

4.2

9.3

P16

ICPC

Acute alcohol abuse

3.7

9.2

103

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

9.2

130

701

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

9.2

126

672

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

9.1

107

535

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

3.8

9.1

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

9.1

371

R81

ICPC

Pneumonia

2.8

9.1

198

L02

ICPC

Back symptom/complaint

1.9

9.1

139

771

J96.0

ICD-10 Finland

Acute respiratory failure

5.2

9.1

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

9.1

321

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.4

9.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

7.1

9.0

F41.01

ICD-10 Finland

Severe panic disorder

7.1

9.0

F34.1

ICD-10 Finland

Dysthymia

2.5

9.0

266

N05AD01

ATC

haloperidol; systemic

2.9

9.0

181

R4120

NOMESCO Finland

Occupational therapy

2.1

9.0

100

493

N05AD03

ATC

melperone; systemic

6.5

9.0

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.7

8.9

101

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

8.9

372

2708

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

8.9

222

1431

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

5.5

8.9

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

8.9

620

4971

A02BC01

ATC

omeprazole; systemic

1.5

8.9

377

2752

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

8.9

108

551

S06.0

ICD-10 Finland

Concussion

1.8

8.9

150

860

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.9

8.9

132

727

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

12.6

8.9

O47.1

ICD-10 Finland

False labour at or after 37 completed weeks of gestation

2.5

8.9

273

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

8.8

277

1891

M54.3

ICD-10 Finland

Sciatica

2.2

8.8

427

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

8.8

153

885

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

8.8

845

7139

R03BA08

ATC

ciclesonide; inhalant

1.9

8.8

123

660

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.4

8.8

314

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

8.7

296

N30.0

ICD-10 Finland

Acute cystitis

1.7

8.7

177

1078

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

8.6

235

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

11.6

8.6

L84

ICPC

Back syndrome without radiat pain

2.5

8.6

284

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

9.0

8.5

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.1

8.5

143

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

20.1

8.5

WX882

NOMESCO Finland

High dependency care

2.9

8.5

171

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

8.5

196

1237

L11

ICPC

Wrist symptom/complaint

1.9

8.5

117

628

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.3

8.5

122

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

8.4

160

952

E000003

ATC

2.3

8.4

339

K85

ICPC

Elevated blood pressure

1.7

8.4

183

1135

SPAT1285

SPAT

Provision of consultation response

2.2

8.4

361

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

8.4

178

1096

N06AB05

ATC

paroxetine; oral

2.0

8.4

102

520

J01CF05

ATC

flucloxacillin; systemic

2.5

8.4

262

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.8

8.3

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

+∞

8.3

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.1

8.3

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

8.3

205

1317

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.5

8.3

325

2332

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

8.3

315

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

8.3

377

2792

A10AE06

ATC

insulin degludec; parenteral

2.6

8.3

240

T82

ICPC

Obesity

2.4

8.2

267

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

8.2

340

2465

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.8

8.2

182

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.3

8.2

120

TUPKY

NOMESCO Finland

5.2

8.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

8.2

694

5729

Z03

ICPC

Housing/neighbourhood problem

7.6

8.2

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

8.1

137

R03AC12

ATC

salmeterol; inhalant

2.5

8.1

262

S29

ICPC

Skin symptom/complaint other

1.6

8.1

232

1549

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

8.1

118

647

B01AC24

ATC

ticagrelor; oral

2.5

8.1

255

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

17.2

8.1

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.7

8.0

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

8.0

110

589

SPAT1229

SPAT

Assessment of need for aid

2.0

8.0

493

A10AE05

ATC

insulin detemir; parenteral

2.0

8.0

467

J42

ICD-10 Finland

Unspecified chronic bronchitis

5.3

8.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

8.0

161

977

R10.0

ICD-10 Finland

Acute abdomen

2.6

8.0

232

H3600, E103

ICD-10 Finland

3.7

8.0

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

8.0

318

L99

ICPC

Musculoskeletal disease other

3.8

7.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

7.9

135

779

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

7.9

331

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

7.9

365

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

7.8

7.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

7.8

465

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

7.8

179

1126

N05CF02

ATC

zolpidem; oral

1.5

7.8

254

1748

F60.2

ICD-10 Finland

Dissocial personality disorder

10.8

7.8

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

9.4

7.8

N06AA09

ATC

amitriptyline; systemic

1.8

7.8

137

799

P28

ICPC

Limited function/disability (P)

4.9

7.8

K92.0

ICD-10 Finland

Haematemesis

3.0

7.8

142

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

7.8

203

1326

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.4

7.8

267

D07AC01

ATC

betamethasone; topical

1.4

7.7

490

3843

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

7.7

257

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

7.7

229

1539

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

45.2

7.7

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

3.1

7.7

126

R52.9

ICD-10 Finland

Pain, unspecified

1.8

7.7

122

687

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.3

7.7

321

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.1

7.7

-69

ICPC

Other reason for encounter NEC

2.4

7.7

259

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.7

7.7

190

P06

ICPC

Sleep disturbance

1.8

7.7

141

832

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

7.6

182

1160

C10AA07

ATC

rosuvastatin; oral

1.5

7.6

316

2291

K90

ICPC

Stroke/cerebrovascular accident

3.0

7.6

144

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.0

7.6

470

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

8.1

7.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

7.6

132

767

Z00.0

ICD-10 Finland

General medical examination

1.5

7.6

271

1903

J37.0

ICD-10 Finland

Chronic laryngitis

2.5

7.6

216

ZX120

NOMESCO Finland

Intravenous

1.8

7.6

137

804

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

7.6

227

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.5

7.6

227

SPAT1284

SPAT

Extensive health certificate

2.6

7.6

201

P01BA02

ATC

hydroxychloroquine; oral

1.9

7.6

114

633

E87.6

ICD-10 Finland

Hypokalaemia

2.9

7.6

155

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.2

7.6

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

7.5

464

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.3

7.5

112

D09AB01

ATC

zinc bandage without supplements; topical

3.5

7.5

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.8

7.5

163

UJF32

NOMESCO Finland

Coloscopy

1.4

7.5

336

2474

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

3.2

7.5

118

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

7.4

131

766

Z71.8

ICD-10 Finland

Other specified counselling

1.4

7.4

362

2708

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

7.4

101

542

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

4.6

7.4

O99.80

ICD-10 Finland

The fear of childbirth

2.1

7.3

398

N01

ICPC

Headache

1.7

7.3

150

913

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

7.3

411

GDC00

NOMESCO Finland

Lobectomy of lung

8.4

7.3

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

10.9

7.3

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.8

7.3

160

L30.3

ICD-10 Finland

Infective dermatitis

2.4

7.3

246

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

7.3

177

1135

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.9

7.3

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

5.2

7.2

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

5.5

7.2

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

7.2

346

SPAT1379

SPAT

Health check-up of pregnant person

1.6

7.2

188

1224

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.7

7.2

171

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

7.2

116

657

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.3

7.2

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

7.3

7.2

SPAT1210

SPAT

Application of cast or individual aid

2.3

7.2

292

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

7.2

152

939

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

7.2

326

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

7.2

397

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

20.1

7.1

R55

ICD-10 Finland

Syncope and collapse

1.7

7.1

140

846

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

5.0

7.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

7.1

468

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

7.1

307

R74

ICPC

Upper respiratory infection acute

1.4

7.1

452

3545

D11

ICPC

Diarrhoea

1.6

7.1

173

1108

SPAT1151

SPAT

Treatment of major wounds

4.0

7.1

Z35.6

ICD-10 Finland

Supervision of very young primigravida

12.1

7.1

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

6.1

7.1

E000001

ATC

1.5

7.1

297

2156

-60

ICPC

Result test/procedure

2.0

7.1

442

SPAT1146

SPAT

Puncture of abscess or incision of skin

3.2

7.1

112

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.2

7.0

297

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.4

7.0

237

L72.1

ICD-10 Finland

Trichilemmal cyst

1.9

7.0

515

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

10.1

7.0

E66

ICD-10 Finland

Obesity

2.2

7.0

322

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

3.4

7.0

N06AA04

ATC

clomipramine; systemic

3.4

7.0

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.9

7.0

138

R29

ICPC

Respiratory symptom/complaint other

2.0

7.0

477

SPAT1265

SPAT

Breathalyser

4.5

7.0

ZXA00

NOMESCO Finland

Right side

1.4

7.0

346

2597

N06AX03

ATC

mianserin; oral

2.1

7.0

373

OAB43

SPAT

0.6

7.0

129

1989

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1168

7222

2.52

85.09

8.6

6.8

mmol/l

1.2

2.34

1055

6107

(3032080) INR in Blood by Coagulation assay

1007

5918

2.43

80.60

7.8

8.2

inr

1.1

1.2

1.35

247

1812

(3023368) Bacteria identified in Blood by Culture

762

3957

2.51

80.06

4.7

4.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1362

9210

2.55

79.14

6.5

4.8

mmol/l

6.9

6.6

2.79

1284

8528

(3021447) Carbon dioxide [Partial pressure] in Venous blood

358

1283

3.19

76.54

4.6

3.8

kpa

6.0

5.8

0.94

353

1243

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1227

8008

2.41

75.58

6.2

umol/l

9.4

11.4

5.26

1153

7601

(3002032) Base excess in Venous blood by calculation

354

1275

3.17

74.95

4.6

3.8

mmol/l

2.2

1.9

0.69

299

1008

(3012544) pH of Venous blood

361

1317

3.13

74.76

4.6

3.9

—

7.4

—

(3016502) Oxygen saturation in Arterial blood

387

1481

3.01

73.63

8.2

9.0

94.2

95.7

3.33

375

1433

(3014576) Chloride [Moles/volume] in Serum or Plasma

438

1837

2.78

70.01

8.1

7.5

mmol/l

104.2

104.4

0.30

426

1799

(3027801) Oxygen [Partial pressure] in Arterial blood

407

1643

2.86

69.95

8.2

8.5

kpa

11.0

12.4

7.61

394

1577

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

407

1643

2.86

69.95

8.2

8.5

kpa

5.4

5.1

3.50

395

1572

(3004119) Hemoglobin [Mass/volume] in Venous blood

267

848

3.49

69.09

3.8

3.1

g/l

133.9

130.8

1.22

262

831

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

799

4466

2.33

68.78

2.7

2.2

u/l

167.5

221.2

1.29

761

4220

(3003396) Base excess in Arterial blood by calculation

404

1638

2.84

68.77

8.3

8.5

mmol/l

1.6

1.0

1.65

319

1282

(3001604) Monocytes [#/volume] in Blood

1206

8037

2.29

67.44

7.2

5.9

e9/l

0.6

20.44

1097

7032

(3013650) Neutrophils [#/volume] in Blood by Automated count

1335

9284

2.36

67.42

10.4

9.0

e9/l

5.0

4.1

41.83

1232

8171

(3006315) Basophils [#/volume] in Blood

1209

8067

2.29

67.38

7.2

5.9

e9/l

0.0

12.39

1098

7052

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

847

4884

2.29

67.37

3.5

2.6

u/l

52.1

56.7

2.65

783

4538

(3013115) Eosinophils [#/volume] in Blood

1237

8351

2.29

66.74

7.7

6.2

e9/l

0.2

5.89

1133

7424

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

933

5630

2.25

66.10

4.7

3.3

ng/l

60.7

52.2

0.20

659

3569

(3028707) Methadone [Presence] in Urine by Screen method

155

351

4.71

63.92

7.3

2.5

—

(3019198) Lymphocytes [#/volume] in Blood

1221

8308

2.23

63.06

7.3

5.9

e9/l

2.1

2.0

1.88

1112

7408

(3027273) Bicarbonate [Moles/volume] in Venous blood

219

651

3.66

62.47

4.6

3.4

mmol/l

25.7

25.0

1.66

214

629

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1026

6537

2.19

62.26

7.9

6.1

mmol/l

1.2

2.55

951

5951

(3007853) Bacteria identified in Skin by Aerobe culture

421

1862

2.60

59.65

2.2

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

490

2332

2.47

59.40

2.6

1.8

1.7

1.5

5.70

429

2071

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1573

12084

2.49

58.25

9.0

7.4

u/l

80.8

75.7

4.01

1513

11417

(3024561) Albumin [Mass/volume] in Serum or Plasma

988

6381

2.10

55.78

5.4

5.0

g/l

34.4

36.0

13.20

937

5973

(3002173) Hemoglobin [Mass/volume] in Arterial blood

333

1373

2.72

53.91

9.2

9.5

g/l

123.8

123.1

0.21

322

1326

(3019060) Gas panel - Arterial blood

259

937

3.03

53.45

5.7

5.5

—

(3042936) Bacteria identified in Isolate by Culture

460

2231

2.39

52.75

2.2

2.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1526

11799

2.30

51.77

5.0

3.9

mm/h

13.9

10.7

11.67

1448

10966

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

200

635

3.39

51.27

3.2

2.7

0.7

1.07

194

611

(4010399)

278

1073

2.85

50.90

1.6

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

466

2335

2.30

49.17

2.1

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

391

1829

2.42

48.21

8.3

6.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

655

3795

2.09

47.68

3.0

2.9

ng/l

1328.9

1152.6

0.61

568

3212

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

242

897

2.94

47.60

4.3

3.3

mmol/l

1.8

1.6

0.37

185

654

(3018677) aPTT in Platelet poor plasma by Coagulation assay

460

2325

2.28

47.34

2.2

2.0

29.8

29.6

0.25

450

2246

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

249

941

2.88

47.26

4.4

3.3

kpa

5.4

5.1

2.77

238

885

(3009343) pH of Capillary blood

246

928

2.89

46.83

4.4

3.3

7.4

0.66

128

(3008152) Bicarbonate [Moles/volume] in Arterial blood

235

902

2.82

43.18

10.0

7.9

mmol/l

25.2

24.4

1.74

221

843

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

176

582

3.22

42.05

4.7

6.2

3.1

1.7

10.80

165

545

(3019309) Folate [Moles/volume] in Red Blood Cells

463

2462

2.15

41.36

1.7

nmol/l

1146.0

1169.9

0.21

356

1906

(3007930) Methemoglobin/Hemoglobin.total in Blood

174

577

3.21

41.36

4.7

6.2

0.8

0.9

1.13

164

541

(3019069) Monocytes/100 leukocytes in Blood

1070

7598

1.89

41.25

8.0

6.3

8.1

8.5

4.35

1035

7139

(3006504) Eosinophils/100 leukocytes in Blood

1064

7553

1.89

40.94

7.6

6.0

2.6

2.8

1.60

1028

7058

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

234

921

2.75

40.91

10.4

0.7

0.39

234

916

(40761535) Cells panel - Urine sediment

284

1245

2.50

39.83

3.5

3.2

—

(3026008) Bacteria identified in Urine by Culture

683

4241

1.93

39.31

3.4

2.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

292

1313

2.44

38.69

7.3

8.2

mmol/l

9.2

9.3

0.02

275

1258

(3022096) Basophils/100 leukocytes in Blood

1031

7331

1.85

38.59

7.6

6.1

0.6

0.7

0.89

996

6865

(3022313) Gas panel - Capillary blood

186

668

2.97

38.48

4.5

3.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

230

928

2.67

38.21

10.6

10.5

92.1

94.0

3.60

230

923

(3019150) Specific gravity of Urine by Refractometry

579

3431

1.97

38.02

4.6

3.5

kg/l

1.0

0.14

468

(3037467) Urinalysis macro (dipstick) panel - Urine

1416

11163

1.95

38.01

5.2

4.0

—

(3015736) pH of Urine

899

6155

1.85

37.74

4.2

3.1

—

5.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1082

7844

1.84

37.70

4.5

4.0

—

(3000991) Gas panel - Venous blood

267

1175

2.47

37.00

9.6

—

(42870588) Differential panel, method unspecified - Blood

797

5313

1.84

35.99

6.8

6.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

1073

7848

1.81

35.42

7.7

6.1

25.3

28.3

19.19

1034

7354

(3014111) Lactate [Moles/volume] in Serum or Plasma

281

1290

2.37

35.38

7.9

7.8

mmol/l

1.3

1.4

0.12

270

1240

(3044640) Blood type and Crossmatch panel - Blood

766

5071

1.84

35.18

2.6

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

144

473

3.21

34.68

2.8

2.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

327

1631

2.20

33.72

2.0

1.8

—

(3013512) EKG study

661

4233

1.84

33.42

5.0

3.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1053

7752

1.77

33.10

7.6

5.8

60.3

57.0

17.13

1016

7294

(3011288) Drugs identified in Urine by Screen method

158

564

2.96

32.95

12.9

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

437

2451

2.01

32.94

3.0

3.5

mmol/l

0.8

2.91

415

2313

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

324

1630

2.18

32.62

3.0

4.2

u/l

228.6

243.0

0.74

310

1546

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

321

1616

2.18

32.24

1.9

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1072

7976

1.75

32.07

4.3

3.3

estimate

0.0

0.50

173

1559

(3003458) Phosphate [Moles/volume] in Serum or Plasma

362

1915

2.09

31.95

6.6

6.2

mmol/l

1.1

1.0

1.65

339

1776

(3009261) Glucose [Presence] in Urine by Test strip

1079

8064

1.75

31.57

4.3

3.3

estimate

0.0

1.08

172

1520

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

207

870

2.54

31.45

1.7

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

169

643

2.78

31.31

6.9

2.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

147

520

2.97

31.14

2.6

2.3

ug/l

352.9

462.7

0.37

139

487

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

846

5922

1.75

31.09

2.0

1.9

pmol/l

93.8

95.8

0.63

507

3235

(3020891) Body temperature

157

578

2.86

30.93

7.5

4.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

154

4.75

30.72

3.0

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

576

3613

1.84

30.63

4.1

3.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1065

7983

1.73

30.34

5.7

4.5

estimate

0.0

0.50

182

1602

(3009508) Creatinine [Moles/volume] in Urine

716

4804

1.77

30.32

5.5

3.2

mmol/l

7.7

8.1

1.19

617

4084

(3031040) Bacteria [#/volume] in Urine by Automated count

1322

10545

1.77

29.97

5.1

4.0

e6/l

430.6

1237.6

0.70

135

(1761482) Bacteria [#/volume] in Urine by Culture

109

333

3.41

29.48

5.4

4.1

—

(3000764) Benzodiazepines [Presence] in Urine

194

816

2.53

29.37

6.3

2.0

—

(3016879) Cocaine [Presence] in Urine

184

761

2.56

28.84

6.6

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1837

16469

2.70

28.53

22.5

12.9

mg/l

22.5

22.9

0.19

1655

12881

(3028300) Cannabinoids [Presence] in Urine

193

826

2.48

28.13

6.5

2.0

—

(3017181) Myelocytes/100 leukocytes in Blood

267

1317

2.19

28.00

4.5

4.3

0.8

0.9

0.13

367

(3019550) Sodium [Moles/volume] in Serum or Plasma

1845

16609

2.73

27.78

24.1

14.3

mmol/l

139.0

139.6

17.60

1825

16197

(3029937) Albumin [Presence] in Urine by Test strip

647

4304

1.75

27.68

4.4

3.6

estimate

0.0

1.28

169

1543

(3023103) Potassium [Moles/volume] in Serum or Plasma

1848

16667

2.74

27.38

23.8

14.4

mmol/l

4.0

12.44

1827

16231

(3037522) Nuclear Ab [Titer] in Serum

395

2270

1.93

27.19

1.4

1.3

titre

617.8

503.2

0.48

458

(3017143) Hepatitis C virus Ab [Presence] in Serum

388

2223

1.93

26.93

1.8

1.6

—

(3027008) Opiates [Presence] in Urine

190

824

2.45

26.88

6.4

2.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

177

748

2.50

26.47

10.0

11.3

mmol/l

24.4

24.3

0.21

163

714

(3043409) Potassium [Moles/volume] in Arterial blood

125

442

2.95

26.46

7.0

4.3

mmol/l

3.8

3.9

0.65

119

417

(4198724)

6.09

26.44

3.5

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1394

11473

1.73

26.29

4.6

3.1

u/l

64.7

47.0

4.99

1303

10844

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

590

3880

1.74

25.97

2.4

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

274

1405

2.10

25.91

2.3

g/l

0.2

0.41

243

1314

(3002179) Metamyelocytes/100 leukocytes in Blood

246

1213

2.17

25.72

3.9

4.1

0.3

0.6

1.02

274

(3020682) Albumin/Creatinine [Ratio] in Urine

667

4550

1.70

25.64

4.7

4.1

mg/mmol

15.8

9.7

1.41

490

2959

(3021440) Promyelocytes/100 leukocytes in Blood

251

1250

2.16

25.59

4.6

4.4

0.1

1.62

335

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

149

589

2.65

25.55

4.9

3.6

mmol/l

24.6

24.8

0.35

143

550

(3026782) Osmolality of Urine

477

2963

1.80

25.48

3.2

2.7

mosm/kgh2o

537.6

554.0

0.77

426

2541

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

564

3687

1.74

25.22

1.9

1.7

mg/l

1.1

0.03

429

2773

(3027944) Amphetamines [Presence] in Urine

184

812

2.40

25.01

5.2

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

135

4.55

24.85

1.9

1.5

promille

1.6

1.1

1.33

106

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

202

932

2.30

24.80

3.1

2.3

u/l

11009.4

6597.4

0.59

386

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

848

6218

1.64

24.33

4.5

3.4

—

(3025159) Blasts/100 leukocytes in Blood

236

1181

2.13

23.69

4.6

4.4

0.0

0.4

0.71

287

(3026493) Urate [Moles/volume] in Serum or Plasma

611

4142

1.69

23.65

2.7

2.6

umol/l

2782.5

4872.1

0.84

523

3656

(3015235) Bicarbonate [Moles/volume] in Capillary blood

107

371

2.99

23.45

3.5

2.8

mmol/l

25.8

24.6

1.50

101

336

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

237

1196

2.12

23.26

2.5

2.3

ug/l

7.1

7.6

0.05

210

1080

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

265

3.35

22.96

1.4

u/l

13.4

19.9

1.66

219

(3020630) Protein [Mass/volume] in Serum or Plasma

226

1132

2.13

22.59

1.8

2.7

g/l

66.6

66.9

0.22

209

1054

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

141

577

2.55

22.52

2.1

ug/l

2.3

1.8

0.24

129

526

(3019225) pH of Specimen

266

1418

2.01

22.47

5.3

4.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

102

359

2.94

21.77

1.8

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

566

3837

1.67

21.53

2.4

2.1

mg/l

3.2

2.9

2.29

494

3271

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

750

5455

1.61

21.48

3.8

3.3

u/l

48.3

34.5

0.51

705

5179

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

501

3299

1.70

21.24

1.8

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

846

6354

1.58

21.01

2.4

2.2

nmol/l

70.0

75.2

6.18

774

5806

(3037121) Protein [Mass/volume] in Urine

130

529

2.56

21.00

2.6

3.4

g/l

0.3

0.05

226

(40760892) CBC W Ordered Manual Differential panel - Blood

558

3805

1.65

20.59

5.2

4.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

263

3.21

20.53

1.7

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

690

4969

1.60

20.33

2.7

3.3

mmol/l

2.3

1.86

616

4409

(3022948) Iron [Moles/volume] in Serum or Plasma

379

2351

1.76

19.77

2.8

2.5

umol/l

12.1

13.7

3.62

352

2180

(3009466) Valproate [Moles/volume] in Serum or Plasma

254

3.20

19.71

5.9

5.6

umol/l

352.7

365.2

0.27

220

(3000330) Specific gravity of Urine by Test strip

153

692

2.31

19.60

4.8

3.1

—

(3004616) Nuclear Ab [Presence] in Serum

186

3.58

19.47

1.4

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

593

2.41

19.39

1.4

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

167

789

2.22

19.28

11.4

11.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

494

3320

1.65

19.07

1.6

1.5

nmol/l

18.2

20.6

1.43

430

2884

(3000494) Fungus identified in Specimen by Culture

325

1948

1.80

19.00

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

570

3975

1.61

18.93

4.9

3.9

92.6

91.6

0.41

548

3871

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1678

14998

1.80

18.86

5.7

4.6

mu/l

1.8

1.9

1.00

1569

13914

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

127

539

2.45

18.76

1.5

1.6

iu/ml

127.0

0.3

0.48

(46235355) HIV 1 and 2 tests - Meaningful Use set

568

3967

1.61

18.71

2.1

1.9

—

(3042517) Benzodiazepines panel - Urine

11.98

18.70

2.4

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

148

674

2.29

18.65

4.5

4.1

mmol/l

24.2

0.01

129

603

(3036481) Cortisol [Moles/volume] in Serum or Plasma

268

1529

1.87

18.34

2.2

2.1

nmol/l

383.3

370.9

0.43

246

1419

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

124

528

2.44

18.19

1.5

1.6

titre

872.0

411.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

167

815

2.15

17.76

1.9

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

344

2151

1.73

17.24

2.8

2.5

g/l

2.4

0.72

313

2009

(3023511) Choriogonadotropin [Units/volume] in Urine

116

493

2.44

17.09

1.6

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

411

2703

1.66

17.03

1.3

u/ml

17.1

11.7

0.64

170

1124

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.07

16.69

1.5

3.4

umol/l

94.1

112.6

0.20

(3005322) IgE [Units/volume] in Serum or Plasma

205

1106

1.95

16.56

1.3

u/ml

372.7

220.7

1.64

187

1021

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1446

12579

1.56

16.45

4.7

3.9

pmol/l

14.9

14.6

4.43

1342

11564

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

170

860

2.07

16.44

8.2

mmol/l

25.1

24.7

0.52

170

855

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

277

2.89

16.42

1.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

300

2.81

16.35

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

126

3.88

16.31

1.4

1.1

u/ml

80.6

88.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

321

1999

1.72

16.26

2.9

2.5

21.3

23.7

1.95

274

1723

(3023183) Ammonium ion [Moles/volume] in Plasma

359

2.64

16.20

2.7

3.2

umol/l

31.2

37.3

1.18

308

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

117

512

2.37

16.16

1.5

1.9

—

(3018418) pH of Serum or Plasma

588

4265

1.54

15.96

4.3

4.1

7.4

1.89

109

837

(3012516) Albumin [Mass/volume] in Urine

594

4328

1.53

15.75

3.9

3.3

mg/l

330.6

251.2

0.22

438

2846

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

208

3.15

15.73

1.3

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

423

2861

1.61

15.50

1.3

iu/ml

63.1

30.0

1.56

136

899

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

186

3.24

15.25

1.3

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1866

17502

2.24

14.97

23.3

14.6

umol/l

75.7

76.0

0.16

1866

17496

(3027945) Reticulocytes/100 erythrocytes in Blood

255

1523

1.77

14.89

2.7

1.9

1.8

1.68

222

1361

(3005719) IgG [Mass/volume] in Serum or Plasma

220

1257

1.84

14.87

2.1

2.6

g/l

10.2

10.5

0.40

197

1160

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

191

1047

1.91

14.68

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

130

623

2.16

14.47

1.9

g/l

1.7

1.5

1.93

120

539

(3021589) Normoblasts [#/volume] in Blood

900

7221

1.45

14.45

11.9

9.2

e9/l

0.0

0.47

776

5958

(3021901) Oxygen saturation in Capillary blood

264

2.79

14.32

2.7

2.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

153

3.40

14.27

1.5

g/l

34.5

33.0

0.31

133

(3004588) Protein electrophoresis panel - Serum or Plasma

172

922

1.95

14.12

1.7

2.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

276

1712

1.71

14.06

19.8

21.5

inr

1.3

0.02

247

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

404

2.42

14.01

1.2

—

5.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

245

2.84

13.98

1.4

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

381

2572

1.60

13.92

3.4

2.6

e6/l

1.4

1.0

1.93

264

1471

(3026389) Candida sp identified in Specimen by Organism specific culture

202

3.03

13.92

1.5

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

572

4226

1.50

13.87

3.8

3.0

e6/l

0.5

0.4

0.33

477

3194

(3018095) Leukocytes [#/volume] in Urine

713

5503

1.46

13.87

4.4

3.5

e6/l

89.7

77.2

0.18

551

3841

(3028308) Erythrocytes [#/volume] in Pleural fluid

122

3.67

13.86

1.5

1.4

e6/l

27350.8

40329.4

0.25

(3017569) Oxygen content in Arterial blood

4.46

13.57

2.2

2.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

185

1030

1.88

13.55

4.2

4.1

ng/l

95.6

89.2

0.28

168

914

(40758558) Short blood count panel - Blood

545

4008

1.50

13.44

8.0

6.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

121

581

2.15

13.41

2.3

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

134

3.41

12.77

1.5

1.4

e6/l

2252.2

1668.7

0.27

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1822

0.44

12.63

1.5

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

448

3199

1.52

12.62

3.0

2.5

e6/l

7.0

5.8

0.90

413

2827

(3050129) First trimester maternal screen panel - Serum or Plasma

157

854

1.91

12.34

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

1972

0.47

12.25

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

347

2360

1.57

12.14

2.2

2.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1859

17567

2.02

12.09

14.0

9.7

u/l

28.1

27.1

0.74

1826

17025

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

110

532

2.13

11.99

2.2

1.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

107

512

2.15

11.98

1.7

1.6

g/l

1.2

0.20

102

483

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

215

2.80

11.92

1.4

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

397

2799

1.52

11.78

4.6

3.5

ng/l

691.0

461.4

0.34

307

2013

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

412

2.27

11.67

2.0

3.6

mg/l

74.8

46.9

0.31

327

(3034860) Kappa light chains.free [Mass/volume] in Serum

412

2.27

11.67

2.0

3.6

mg/l

49.9

69.4

0.58

326

(3023520) Reticulocytes [#/volume] in Blood

190

1118

1.77

11.60

2.6

e9/l

75.0

71.6

0.65

149

854

(3040151) Glucose [Moles/volume] in Capillary blood

157

3.04

11.10

5.5

6.9

mmol/l

8.2

7.3

0.62

132

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1614

14772

1.51

11.01

7.5

5.3

mmol/mol

41.6

39.2

14.02

1518

13846

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

281

1869

1.59

10.75

4.7

4.2

31.0

31.7

0.47

228

1312

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

427

2.19

10.73

1.3

1.2

u/ml

9.4

2.5

0.42

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

356

2.30

10.71

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

596

4638

1.41

10.41

4.1

3.1

e6/l

81.5

87.0

0.06

504

3578

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1254

0.40

10.32

1.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

369

2629

1.50

10.29

2.3

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

192

1175

1.70

10.19

3.5

3.9

mmol/l

1.2

0.62

172

1023

(1761868) Lipid panel - Serum or Plasma

500

6423

0.70

10.18

3.9

2.6

—

(3019977) pH of Arterial blood

3.91

10.13

3.1

3.3

7.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

464

2.10

10.13

2.9

u/ml

0.3

0.18

250

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1673

15499

1.53

10.05

17.2

11.6

ml/min/173m2

88.9

85.9

5.56

1436

12742

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

432

2.14

10.04

1.4

1.2

u/ml

3.2

10.8

1.18

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

401

2.17

9.91

2.0

3.6

ratio

1.3

3.0

—

(3045788) Cell count panel - Pleural fluid

105

3.38

9.87

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.65

9.82

1.2

1.1

—

(40761511) CBC panel - Blood by Automated count

1835

17405

1.79

9.76

20.8

12.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.48

9.75

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

223

1437

1.62

9.70

1.4

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

309

2.31

9.57

2.2

3.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

223

2.56

9.57

3.4

3.5

0.7

1.2

0.76

188

(3044242) Glucose [Moles/volume] in Arterial blood

3.66

9.28

2.2

2.7

—

(3003181) Sodium [Moles/volume] in Urine

228

2.50

9.16

1.5

1.3

mmol/l

47.9

66.0

2.04

190

(3028026) IgM [Mass/volume] in Serum or Plasma

162

975

1.72

9.14

1.6

1.8

g/l

1.5

1.4

0.22

140

904

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

5.97

9.12

2.4

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

241

2.45

9.09

1.1

g/l

1.6

1.5

1.66

221

(40768806) Pleura Pathology biopsy report

127

3.03

9.02

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

265

1808

1.54

9.00

2.6

2.7

umol/l

10.1

7.7

0.66

220

1564

(3024928) Oxygen saturation in Venous blood

301

2.27

8.82

2.9

3.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

129

2.98

8.79

14.8

13.5

nmol/l

686.2

850.9

1.41

124

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

258

2.37

8.74

1.1

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

354

2578

1.45

8.72

2.3

3.0

mmol/l

2.4

0.16

321

2278

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

284

2.30

8.68

1.1

iu/ml

12.7

1761.1

0.54

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

416

3124

1.42

8.67

1.7

pmol/l

411.9

36708334.1

3.31

351

2667

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

196

1262

1.61

8.54

2.4

2.5

ml/min/173m2

71.4

70.1

0.12

451

(40757494) Bilirubin.total [Moles/volume] in Blood

3.54

8.53

2.1

2.0

—

37.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

352

2.15

8.49

1.9

1.7

e6/l

21936.2

12990.9

0.45

259

(3042631) Mycobacterium sp identified in Specimen

189

2.58

8.43

2.6

2.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

161

2.71

8.34

3.5

3.9

—

(3006653) Thiamine [Moles/volume] in Blood

3.45

8.23

1.2

1.5

nmol/l

160.4

145.0

0.38

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

370

2.10

8.22

2.3

2.5

ug/min

231.9

126.2

0.57

232

(3001019) Free T4 and TSH panel - Serum or Plasma

1038

0.42

8.03

1.4

1.7

—

(3000492) Spirometry study

245

1684

1.52

8.02

1.5

1.4

—

(3012441) Differential panel - Pleural fluid

120

2.95

7.98

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

168

1060

1.64

7.95

2.6

2.8

ng/l

204.1

160.3

0.60

157

961

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

486

3797

1.37

7.93

1.3

u/ml

1.2

1.7

0.46

152

1050

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

330

2415

1.44

7.87

3.7

2.8

e6/l

4.6

2.3

2.79

215

1320

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

345

2.10

7.74

3.0

2.1

nmol/l

0.9

0.8

0.05

294

(3007164) IgA [Mass/volume] in Serum or Plasma

434

3341

1.38

7.74

1.4

g/l

2.6

2.4

0.38

277

2128

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

174

2.56

7.69

1.3

1.8

—

(3036489) Thrombin time

111

631

1.80

7.65

1.8

1.9

20.2

21.3

1.62

554

(4015189)

4.75

7.64

2.9

2.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

113

649

1.79

7.53

1.3

1.2

u/ml

0.3

1.1

0.88

(3044889) 12 lead EKG panel

1237

11089

1.31

7.50

3.9

3.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.25

7.48

1.4

1.1

—

(3037756) Immunofixation for Serum or Plasma

271

2.21

7.42

1.5

1.7

—

(36304419) Bacteria [Presence] in Urine

523

4170

1.35

7.42

3.7

2.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

392

2.00

7.42

1.3

1.4

e6/l

70.5

34.7

0.23

304

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

392

2.00

7.42

1.4

1.5

e6/l

307.3

1005.3

0.64

316

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

121

2.84

7.28

2.4

1.4

—

(3047181) Lactate [Moles/volume] in Blood

466

1.91

7.25

6.7

7.2

mmol/l

1.1

1.3

2.01

403

(4034850)

524

1.85

7.23

13.2

9.2

—

(3007463) Buprenorphine [Presence] in Urine

15.80

7.23

2.1

4.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

177

1158

1.58

7.22

2.4

au/ml

53.7

20.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

385

1.99

7.07

1.4

1.7

—

(1616796) Gas panel - Central venous blood

337

2.05

7.06

4.7

3.7

—

(3052851) Hemolysis interference index of Serum or Plasma

435

1.92

7.04

4.1

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.12

6.81

3.5

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.12

6.81

3.5

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

281

2.13

6.81

1.5

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

315

2.07

6.78

3.0

2.6

17.0

16.4

0.50

166

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

204

1401

1.51

6.69

2.6

4.3

ug/l

20.8

21.2

0.01

188

1134

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.03

6.62

1.4

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

151

2.55

6.62

1.3

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.74

6.59

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

285

2.10

6.58

1.7

3.7

u/ml

183.4

247.5

0.15

266

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

119

722

1.69

6.57

1.6

2.0

u/l

43.2

39.2

1.27

111

643

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

170

2.44

6.54

3.4

1.9

mg/l

19.5

19.2

0.02

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.83

6.53

1.4

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

286

2.10

6.52

1.4

2.2

umol/l

3.3

5.0

2.00

211

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

404

1.92

6.51

1.6

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

112

2.80

6.49

1.5

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

180

1216

1.53

6.38

2.1

1.8

—

(3039000) Anion gap in Blood

323

2.01

6.36

6.9

8.7

mmol/l

10.7

11.5

1.14

292

(3045716) Anion gap in Serum or Plasma

3.05

6.35

2.8

2.7

mmol/l

8.7

9.5

0.39

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

429

1.88

6.35

2.5

2.0

iu/l

177.1

4.8

0.48

168

(3018572) Chloride [Moles/volume] in Blood

324

2.01

6.31

6.9

8.7

mmol/l

103.8

105.5

1.50

293

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

455

1.84

6.17

1.8

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

3.31

6.14

1.1

1.0

u/ml

5.3

9.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

377

1.92

6.12

1.4

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

128

2.60

6.05

1.1

—

(3020491) Glucose [Moles/volume] in Blood

128

2.60

6.05

1.8

mmol/l

7.3

6.6

0.42

(3000570) Elastase.pancreatic [Mass/mass] in Stool

458

1.82

6.05

1.4

1.5

ug/g

274.7

293.8

0.32

262

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.26

6.00

1.0

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

445

1.83

5.98

1.7

2.1

mg/l

11.2

10.8

0.21

413

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.70

5.92

1.4

1.1

—

(4027681)

124

2.61

5.89

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

293

2.01

5.78

1.2

u/ml

11.6

4.2

0.57

100

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.09

5.77

4.0

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1662

15732

1.36

5.71

5.2

4.2

mmol/l

6.3

5.9

17.00

1541

14525

(3039443) Prostate specific Ag panel - Serum or Plasma

411

0.24

5.70

1.4

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

157

2.38

5.65

1.4

1.8

—

(44806118)

195

2.23

5.65

1.2

1.6

—

(44790047)

195

2.23

5.65

1.2

1.6

—

(44790049)

195

2.23

5.65

1.2

1.6

—

(44790048)

195

2.23

5.65

1.2

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

242

2.09

5.59

1.2

u/l

42.7

38.4

0.10

207

(3006184) Hemoglobin [Mass/volume] in Capillary blood

333

1.92

5.53

2.3

g/l

131.1

130.7

0.03

249

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.64

5.48

2.6

2.2

umol/l

14.2

14.4

0.03

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

286

1.99

5.43

1.3

1.2

u/ml

5.8

5.5

0.04

127

(44813793)

112

2.61

5.39

1.3

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

306

2351

1.36

5.39

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

130

2.49

5.38

1.1

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

529

1.71

5.35

1.9

2.0

95.0

91.5

0.63

496

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.56

5.33

1.2

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

2.47

5.30

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

2.47

5.30

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

2.47

5.30

1.3

1.6

—

(4146454)

162

2.31

5.29

3.0

2.6

—

(3044290) Cell count panel - Cerebral spinal fluid

368

1.85

5.25

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.35

5.16

3.3

4.8

—

(3005570) Glucose [Moles/volume] in Urine

164

2.28

5.15

1.8

2.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

140

2.38

5.07

2.7

3.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.71

5.01

1.7

2.5

g/l

4.7

3.8

0.45

381

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.71

5.01

1.7

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.71

5.01

1.7

2.5

g/l

7.7

7.3

1.09

401

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

199

2.13

4.99

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

150

1030

1.49

4.96

3.8

3.4

pmol/l

4.6

4.5

0.06

132

915

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

213

2.09

4.96

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

204

1488

1.41

4.92

3.2

2.4

u/l

31.3

40.4

1.41

173

1279

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

112

2.52

4.88

2.6

1.8

—

(4268621)

201

2.11

4.88

2.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

211

1553

1.40

4.83

2.6

1.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

4.78

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

139

2.32

4.69

3.0

2.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

136

928

1.50

4.65

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

500

1.67

4.53

2.9

2.3

g/l

3.9

3.7

0.67

470

(3001122) Ferritin [Mass/volume] in Serum or Plasma

841

7459

1.22

4.53

3.1

2.8

ug/l

135.6

117.6

0.79

774

6974

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.78

4.53

1.3

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

306

1.85

4.51

2.0

1.8

—

(3023419) Bacteria identified in Sputum by Culture

201

2.06

4.50

2.1

2.6

—

(40768797) Stomach Pathology biopsy report

279

2173

1.33

4.47

1.4

1.2

—

(3012501) Base excess in Blood by calculation

336

1.81

4.47

5.5

4.6

mmol/l

3.3

2.3

1.33

220

(3024263) Appearance of Synovial fluid

2.78

4.45

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.02

4.44

1.2

ng/l

42.4

114.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

452

1.69

4.34

1.2

titre

114.2

93.6

0.16

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.35

4.32

1.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

304

1.83

4.29

1.7

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

304

1.83

4.29

1.7

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.80

4.29

1.3

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

139

2.25

4.25

2.4

3.5

62.8

54.3

1.53

101

(3017732) Neutrophils [#/volume] in Blood

159

1140

1.43

4.24

3.5

3.0

e9/l

4.8

4.2

2.85

114

932

(3028433) Virus identified in Specimen by Culture

3.15

4.21

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.76

4.18

1.3

1.4

—

(3008898) HLA-B27 [Presence]

100

655

1.55

4.16

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.00

4.12

1.1

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

467

1.65

4.11

1.7

2.5

g/l

9.5

10.3

0.95

410

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

181

2.06

4.11

1.1

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

294

1.82

4.10

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

148

2.18

4.09

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

116

2.35

4.09

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.36

4.09

1.3

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.53

4.05

1.2

1.1

—

(3010421) pH of Blood

401

1.69

4.01

5.4

4.4

7.4

1.09

332

(4306422)

275

1.84

3.98

1.1

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

150

2.15

3.97

1.3

1.4

nmol/l

1.5

0.05

138

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1637

15641

1.28

3.95

4.5

3.7

mmol/l

1.5

1.3

19.12

1508

14586

(3044941) Cell count panel - Synovial fluid

240

1.90

3.94

1.6

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

466

1.63

3.90

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

145

2.16

3.87

1.3

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

269

3359

0.77

3.87

2.3

2.9

ug/l

0.6

0.7

3.08

180

2132

(3045414) Leukocytes [Presence] in Urine

104

701

1.51

3.82

1.9

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.54

3.77

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

464

1.62

3.73

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

473

1.61

3.69

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

196

1.96

3.68

1.1

1.3

nmol/l

0.1

0.4

—

(3021788) Differential panel - Synovial fluid

275

1.80

3.68

1.8

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

142

2.13

3.65

1.6

1.3

e6/l

45082.6

81121.8

0.25

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.43

3.64

1.5

1.2

—

(3007461) Platelets [#/volume] in Blood

1897

18571

1.57

3.63

32.1

18.8

e9/l

270.4

251.9

24.48

1869

18150

(3044927) Protein electrophoresis panel - Urine

143

2.11

3.59

1.1

1.2

—

(3035880) pH of Pleural fluid

2.66

3.56

1.1

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

323

1.72

3.56

1.5

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

265

1.79

3.49

1.5

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

193

1.93

3.49

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

193

1.93

3.49

1.2

1.5

—

(3024731) MCV [Entitic volume]

1897

18583

1.55

3.47

32.0

18.8

91.9

90.6

23.19

1882

18363

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

204

1577

1.33

3.46

4.5

3.2

—

(3048689) Calprotectin [Mass/mass] in Stool

263

2105

1.29

3.46

2.3

2.5

ug/g

143.8

121.8

0.46

203

1661

(3035941) MCH [Entitic mass]

1897

18584

1.55

3.45

31.9

18.7

30.6

30.3

10.46

1882

18361

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

139

2.10

3.44

4.9

2.4

—

(3026361) Erythrocytes [#/volume] in Blood

1897

18586

1.55

3.43

32.2

18.8

e12/l

4.5

11.73

1865

18140

(3025468) Yersinia sp identified in Specimen by Organism specific culture

188

1.93

3.39

1.2

1.5

—

(3010813) Leukocytes [#/volume] in Blood

1897

18590

1.54

3.37

32.2

18.9

e9/l

8.2

6.7

144.23

1865

18144

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

1.92

3.34

1.2

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

175

1.96

3.34

1.1

1.3

nmol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.26

3.34

1.2

1.1

pmol/l

244.0

346.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.73

3.34

1.1

—

42.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

337

1.68

3.33

1.2

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

1897

18594

1.54

3.32

32.3

18.9

g/l

135.4

136.9

4.12

1881

18374

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.63

3.30

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.63

3.30

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

190

1.91

3.30

1.2

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

190

1.91

3.30

1.2

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

102

708

1.46

3.29

2.4

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

386

4542

0.81

3.28

3.4

3.9

21.1

21.2

0.03

169

2093

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.75

3.24

1.8

1.3

umol/l

36.4

51.5

—

(3011412) CD3 cells [#/volume] in Blood

136

2.07

3.22

1.4

2.3

e9/l

1.8

1.3

1.00

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

769

0.59

3.21

1.6

1.7

mg/l

4.7

4.0

0.19

531

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

427

1.59

3.20

3.0

3.1

mg/l

1.7

1.5

0.72

392

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

110

2.20

3.19

1.1

1.2

ratio

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

259

1.75

3.15

3.4

3.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

3.14

0.0

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.09

1.3

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

188

1.88

3.06

1.2

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.52

3.05

5.3

6.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

1.4

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

1.4

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

285

1.70

3.03

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

100

2.21

3.00

1.5

2.5

e6/l

570.0

635.7

0.22

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.76

2.98

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

516

4511

1.19

2.98

3.9

3.0

—

(40768443) Skin Pathology biopsy report

648

1.46

2.97

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

134

2.03

2.96

2.0

3.3

mg/l

155.5

38.1

0.59

101

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.55

2.96

1.4

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

295

1.68

2.95

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

591

1.48

2.94

1.5

1.3

u/l

7.7

9.2

1.10

488

(3048929) Epstein Barr virus Ab [Presence] in Serum

616

1.47

2.94

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.44

2.88

2.1

2.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

6.68

2.87

1.0

—

(3025941) Bacteria identified in Stool by Culture

128

951

1.37

2.85

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

260

1.71

2.84

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.35

2.82

1.2

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1707

16532

1.24

2.76

5.3

4.5

mmol/l

2.6

2.8

15.93

1584

15441

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

1.51

2.76

1.8

2.6

g/l

3.2

3.1

0.61

388

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

376

1.56

2.63

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

656

1.42

2.63

1.4

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

162

1.87

2.62

1.1

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

162

1.87

2.62

1.4

1.3

g/l

2.6

3.0

0.49

109

(3024139) IgG subclass 3 [Mass/volume] in Serum

162

1.87

2.62

1.4

1.3

g/l

0.4

0.03

109

(3027135) IgG subclass 1 [Mass/volume] in Serum

162

1.87

2.62

1.4

1.3

g/l

7.3

6.9

0.22

111

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

120

2.01

2.61

1.3

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1684

16306

1.22

2.60

5.0

4.1

mmol/l

4.4

4.7

20.03

1574

15327

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

2.11

2.59

1.7

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.91

2.58

1.3

1.0

mg/g

5.1

7.6

1.32

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.91

2.58

1.6

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.43

2.54

1.0

1.2

—

(4062490)

164

1.84

2.53

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.61

2.53

1.8

1.4

ug/l

9.8

8.8

0.16

(3045424) Erythrocytes [Presence] in Urine

285

1.63

2.52

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

165

1.83

2.49

1.2

1.5

mosm/kgh2o

277.7

282.3

0.51

128

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.47

2.48

1.4

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.82

2.46

1.0

nmol/l

5.0

6.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

116

1.99

2.46

3.3

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

257

1.65

2.43

1.5

1.7

g/l

0.8

0.18

194

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

260

2172

1.23

2.39

1.7

1.8

—

(4024509)

125

1.93

2.35

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.32

2.31

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.38

2.29

1.0

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.63

2.27

1.3

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

171

1.77

2.25

1.3

1.4

pmol/l

239.4

316.9

0.85

134

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.16

2.25

1.0

1.1

137.4

91.6

2.29

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

592

1.40

2.23

1.8

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.05

2.21

1.2

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

644

1.38

2.21

1.4

1.3

miu/ml

138.4

221.5

1.51

309

(3045462) Protein/Creatinine [Ratio] in Urine

5.57

2.21

1.8

3.1

g/mol

40.4

15.5

—

(3001729) Color of Synovial fluid

5.57

2.21

2.0

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.20

2.21

3.1

mg/l

6.0

7.7

0.78

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

385

1.49

2.20

1.2

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.51

2.18

1.2

1.3

57.1

57.3

0.01

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1671

16224

1.20

2.18

4.9

4.1

mmol/l

1.3

1.4

30.17

1553

15169

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.63

2.18

1.2

15.2

31.2

1.14

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.34

2.18

1.5

1.3

—

(3017509) Phencyclidine [Presence] in Urine

3.34

2.18

4.8

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.30

2.15

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.30

2.15

1.3

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.30

2.15

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

189

1.70

2.14

1.2

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.11

2.12

1.6

1.9

140.1

136.2

0.07

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.57

2.09

1.3

4.5

1.8

0.53

(3003694) ABO and Rh group [Type] in Blood

573

5181

1.15

2.09

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

5.01

2.07

1.4

1.2

nmol/l

35.5

12.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

135

1065

1.29

2.06

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

117

1.89

2.06

1.0

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

389

3423

1.17

2.04

1.9

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

147

1.78

2.02

1.1

1.0

mg/l

273.3

283.9

0.30

134

(3051593) INR in Capillary blood by Coagulation assay

2.41

2.02

2.5

15.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.11

2.02

1.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.11

2.02

1.4

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.11

2.02

1.4

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.11

2.02

1.4

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.09

2.01

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.51

2.01

1.0

1.2

g/l

36.3

38.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

443

1.44

2.01

1.5

2.7

g/l

1.7

0.9

0.35

402

(40768800) Prostate Pathology biopsy report

338

0.53

2.00

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.82

2.00

3.4

3.2

—

(3049717) Cytology report of Urine Cyto stain

545

1.39

1.99

3.3

2.6

—

(3004775) Volume in Urine collected for unspecified duration

126

1.84

1.98

1.9

2.3

681.6

641.1

0.17

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.34

1.96

1.1

1.0

—

(3014271) Vancomycin [Susceptibility]

2.20

1.94

2.9

2.6

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

4.55

1.94

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.55

1.94

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

2.97

1.93

1.3

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.76

1.93

1.0

1.1

—

25.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

142

1.77

1.93

1.6

2.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

227

1.60

1.91

2.6

u/ml

56.1

79.6

0.12

209

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.25

1.91

2.0

2.8

umol/l

34.9

30.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

1.88

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

244

1.57

1.87

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

588

0.66

1.87

1.6

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.86

1.86

1.3

—

(40757373) Influenza virus identified in Isolate

2.86

1.86

1.7

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

631

1.35

1.84

2.2

1.8

—

(3024471) HLA-A [Type]

2.21

1.84

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

351

1.47

1.84

1.4

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.54

1.84

4.5

8.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.51

1.83

1.1

1.2

—

0.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

572

0.66

1.81

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

336

1.47

1.80

1.0

1.1

u/ml

9.7

6.8

0.40

165

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

207

1.60

1.80

1.2

1.1

101.1

95.9

0.65

195

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

102

1.87

1.76

1.3

2.2

9.6

13.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

507

1.37

1.75

1.4

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

3.34

1.74

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

1.74

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

186

1.62

1.72

1.5

1.6

61.7

58.9

0.14

117

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.92

1.72

1.0

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.14

1.71

3.5

3.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

357

1.44

1.70

1.2

u/ml

11.5

41.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

126

1.75

1.68

1.1

u/l

1.0

1.1

1.21

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

384

1.42

1.67

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

359

1.43

1.66

1.1

1.2

u/ml

259.9

261.5

0.02

227

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.94

1.64

1.3

1.1

miu/ml

2089.5

1509.0

0.81

(3051387) C reactive protein [Mass/volume] in Capillary blood

335

1.44

1.64

4.2

3.4

mg/l

19.6

26.3

0.95

210

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.25

1.63

3.5

2.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

135

1.71

1.62

1.5

1.6

—

(3005033) Fetal Nuchal fold Thickness US

569

0.68

1.62

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.58

1.61

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.15

1.61

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

106

1.80

1.59

1.9

1.7

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.01

1.58

1.0

3.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.01

1.58

1.2

2.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.01

1.58

2.2

2.3

—

(3024932) HLA-DR beta [Type]

2.11

1.55

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

1.9

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

1.9

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

224

1.53

1.54

1.5

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.04

1.54

1.5

1.1

g/l

0.3

0.53

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

349

1.41

1.52

4.5

5.8

iu/ml

91264.4

325.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

209

1.54

1.51

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.16

1.50

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

376

1.39

1.49

1.1

u/ml

8.0

1.8

0.55

143

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

150

1251

1.22

1.48

1.3

1.2

iu/ml

180.7

152.4

0.30

490

(4035726)

155

1297

1.21

1.48

1.4

—

(36660697) Celiac disease serology panel - Serum

156

1307

1.21

1.47

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

227

1.51

1.47

2.3

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.51

1.45

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.51

1.45

1.0

1.1

95.6

97.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.51

1.45

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.73

1.43

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.73

1.43

2.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.80

1.43

2.4

2.3

112.9

99.0

0.90

(3016018) Differential panel - Cerebral spinal fluid

188

1.55

1.43

1.6

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

103

1.75

1.41

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

321

1.41

1.40

1.0

1.1

u/ml

0.7

1.8

1.04

123

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.26

1.40

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.18

1.40

1.5

1.9

ug/l

155.5

52.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.42

1.39

3.6

2.1

mmol/l

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

2.01

1.38

5.3

5.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.01

1.38

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

119

1.69

1.37

1.1

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

408

1.36

1.37

1.5

2.6

g/l

36.8

38.1

1.09

363

(3003740) Influenza virus B Ag [Presence] in Specimen

323

0.62

1.37

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

323

0.62

1.37

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

120

1.67

1.34

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

224

1.48

1.34

1.3

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.97

1.32

1.1

—

(1002224) Polysomnography panel

795

0.76

1.32

1.0

1.1

—

(3011648) Oxygen content in Venous blood

113

1.69

1.32

2.5

2.1

10.4

11.1

0.34

113

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

121

1.66

1.30

1.7

2.3

e6/l

1001.5

759.1

—

(3000285) Sodium [Moles/volume] in Blood

2.50

1.30

1.3

1.0

—

(3017704) Immunofixation for Urine

1.85

1.30

1.9

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

226

1.47

1.29

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.94

1.27

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

157

1337

1.19

1.27

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.23

1.24

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

131

1.61

1.23

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

131

1.61

1.23

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

131

1.61

1.23

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

101

828

1.23

1.21

1.1

titre

—

141.7

—

(44806420)

2.17

1.21

2.1

2.7

—

(40768804) Tissue Pathology biopsy report

689

6479

1.10

1.19

2.0

—

(40761536) Microorganisms panel - Urine sediment

123

1456

0.83

1.16

3.8

3.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

321

0.65

1.16

1.2

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.57

1.14

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.57

1.14

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.57

1.14

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.00

1.12

1.1

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

135

1.56

1.11

3.5

3.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.97

1.11

1.8

2.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.79

1.11

2.1

2.2

ug/l

26.6

128.9

0.45

(3023410) Appearance of Cerebral spinal fluid

176

1.48

1.10

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

0.51

1.09

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.38

1.09

1.0

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.73

1.09

39.6

32.7

ug/l

7.8

7.3

0.41

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.73

1.09

1.8

2.9

u/ml

470.9

1170.9

1.50

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.65

1.06

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.65

1.06

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

107

1.59

0.99

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

849

0.81

0.99

1.3

iu/l

20.5

23.7

0.45

722

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

468

1.27

0.98

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.18

0.98

1.0

3.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

132

1.52

0.97

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

270

0.66

0.95

1.1

1.0

u/ml

3.6

2.4

—

129

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

312

1.32

0.93

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.23

0.93

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

175

1.43

0.93

1.2

1.4

mmol/l

13.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.73

0.92

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

590

1.23

0.92

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

761

0.81

0.89

1.5

—

(4133840)

1.86

0.87

1.1

1.2

—

(3022621) pH of Urine by Test strip

116

1002

1.17

0.86

4.1

2.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.82

0.86

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

170

1.42

0.85

1.4

1.5

—

(40768446) Kidney Pathology biopsy report

1.67

0.85

1.6

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.57

0.84

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

0.52

0.83

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

562

1.22

0.82

1.5

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

1532

15598

0.92

0.82

21.4

13.5

38.6

40.3

6.46

958

11903

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.65

0.81

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

198

1.37

0.80

1.8

1.6

mmol/l

8.1

7.5

0.48

116

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

122

1.48

0.80

1.4

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.73

0.79

1.0

1.1

97.8

115.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.63

0.78

1.0

1.1

—

(3022145) Colonoscopy Study observation

198

1789

1.12

0.78

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

331

1.27

0.78

1.4

u/ml

113.5

117.7

0.10

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

652

1.19

0.74

1.6

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

667

0.82

0.74

2.3

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.64

0.73

1.2

1.9

—

(4281824)

135

0.59

0.73

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.00

0.72

12.0

4.9

mmol/l

3.6

6.6

—

(3051651) Icteric interference index of Serum or Plasma

1.53

0.72

3.2

3.9

—

(3032057) Clostridioides difficile [Presence] in Stool

1.93

0.70

1.4

1.9

—

(40768795) Lymph node Pathology biopsy report

146

0.61

0.69

1.2

—

(3034426) Prothrombin time (PT)

1.53

0.68

1.2

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

144

1.39

0.68

1.5

1.4

42.9

34.2

0.43

(1617658) Protocol used for examination of sentinel lymph nodes

120

0.58

0.67

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.79

0.66

4.6

5.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.73

0.64

1.2

1.4

—

191.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

153

0.65

0.62

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

121

1.41

0.62

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

217

1.29

0.61

3.1

3.0

nmol/l

0.9

0.27

167

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

262

1.26

0.61

1.6

1.4

mmol/l

7.3

7.2

0.07

187

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

178

1941

0.91

0.58

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.51

0.58

1.3

1.0

—

(3004451) EKG impression Narrative

1.48

0.57

1.7

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.48

0.57

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

485

1.18

0.56

1.2

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

1.62

0.55

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.62

0.55

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.62

0.55

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.62

0.55

1.2

1.1

—

(3002256) Pathology report gross observation

188

2037

0.91

0.55

1.2

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.58

0.54

1.0

1.1

—

(40768793) Breast Pathology biopsy report

328

0.79

0.54

1.3

—

(3006270) Folate [Moles/volume] in Blood

125

1.36

0.53

1.2

1.1

nmol/l

241.6

380.1

—

113

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.49

0.53

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.43

0.52

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.50

0.49

1.1

1.2

g/l

—

0.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

520

1.16

0.49

2.5

3.7

u/ml

228.3

2820.9

0.73

440

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.43

0.49

1.1

1.2

iu/ml

328.6

214.3

0.36

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.43

0.49

1.1

1.3

umol/l

12.0

30.8

5.10

(40768441) Liver Pathology biopsy report

110

1.37

0.48

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

155

1430

1.09

0.46

2.5

2.2

nmol/l

11.7

12.9

0.88

135

1281

(4094501)

429

0.84

0.46

1.2

1.1

—

(21494434) Karyotype in Bone marrow

129

1.32

0.45

1.1

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

112

1.34

0.44

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

265

1.21

0.44

2.8

2.9

—

2050.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.66

0.42

1.5

2.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.36

0.41

1.0

ng/l

29.9

43.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

298

2837

1.06

0.40

1.7

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

279

1.19

0.39

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.39

0.38

1.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

694

0.89

0.37

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1185

11663

1.04

0.37

3.3

3.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.35

0.37

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

152

1.25

0.37

1.2

u/l

45.9

53.4

—

110

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.29

0.36

1.1

1.8

—

(3006462) Nitrate [Presence] in Urine

1.29

0.36

3.1

2.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.29

0.36

1.1

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.65

0.35

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

117

1.28

0.35

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.33

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

697

0.90

0.33

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

697

0.90

0.33

1.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

341

1.15

0.32

2.6

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

696

0.90

0.32

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

174

1.21

0.31

1.7

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

138

1.23

0.30

1.1

1.2

u/ml

0.3

0.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

591

1.10

0.30

1.8

1.5

—

(4211845)

1.34

0.30

3.1

2.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.29

0.30

1.6

u/field

1.5

4.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.23

0.29

3.1

3.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

252

1.15

0.27

1.0

1.1

u/ml

2.2

4.6

0.70

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

328

1.13

0.27

2.2

3.9

59.4

57.2

0.82

328

(3025130) Human papilloma virus identified in Specimen

244

1.15

0.25

2.2

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

0.86

0.25

1.1

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.7

—

21.7

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(4212803)

0.00

0.21

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(3003338) MCHC [Mass/volume]

1455

14442

1.03

0.21

27.6

16.1

g/l

332.5

333.2

2.24

1449

14344

(3010726) Horse dander IgE Ab [Units/volume] in Serum

316

1.11

0.20

1.0

1.1

u/ml

1.1

2.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.25

0.20

1.9

1.5

—

10.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

6.9

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

811

1.06

0.19

1.8

1.6

mu/l

355.3

286.5

0.70

725

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

415

4244

0.97

0.19

1.7

1.6

mmol/l

1.6

1.4

4.18

367

3594

(3016750) Collection duration of Urine

100

1.20

0.18

1.5

2.2

min

467.5

500.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

604

1.06

0.15

2.0

1.8

nmol/l

47.1

39.5

0.86

585

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.82

0.13

1.1

1.2

—

(3036603) Volume of Urine

104

1.15

0.12

1.4

1.5

1802.0

1956.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

278

1.08

0.12

1.0

1.1

u/ml

19.5

4.2

0.39

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

230

0.91

0.11

1.7

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

172

1.11

0.11

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

465

0.95

0.11

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

560

5663

0.98

0.11

3.8

4.5

ug/l

3.1

2.4

0.19

487

5131

(3037556) Urate [Mass/volume] in Serum or Plasma

1.11

0.09

1.0

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

320

0.94

0.09

1.3

1.5

nmol/l

0.4

0.10

268

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.06

0.09

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.03

0.08

1.3

1.2

—

(3000012) Reticulocyte production index

1.04

0.08

1.0

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.03

0.07

1.1

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

264

0.95

0.06

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.11

0.05

8.8

7.4

u/ml

58.6

—

(3002385) Erythrocyte distribution width [Ratio]

1402

14055

0.99

0.05

25.4

15.5

14.1

13.6

28.11

1389

13762

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

911

1.02

0.05

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

347

1.04

0.04

1.5

1.4

pmol/l

159.3

166.3

0.03

340

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

101

1.09

0.04

2.7

2.9

40.8

42.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

118

0.93

0.02

1.4

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

298

0.97

0.02

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

101

0.99

0.00

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

235

1.02

0.00

1.0

u/ml

0.3

0.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

181

0.99

0.00

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

106

1.04

0.00

1.5

1.2

—

(3045142) Bone marrow Pathology biopsy report

166

1.02

0.00

1.3

1.4

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

21.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.6

—

1.5

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.4

—

1211.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.6

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

36.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.91

0.00

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.01

0.00

1.4

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

3.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

8.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.9

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Z21_TOBAC_USE and mortality.

Females

Parameter	HR [95% CI]	p-value
Z21_TOBAC_USE	4.091 [3.36, 4.98]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 563 out of 6759 females with Z21_TOBAC_USE died.

Males

Parameter	HR [95% CI]	p-value
Z21_TOBAC_USE	3.572 [3.04, 4.19]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.014

During the follow-up period (1.1.1998 — 31.12.2019), 1187 out of 5385 males with Z21_TOBAC_USE died.

Mortality risk

Mortality risk for people of age

years, who have Z21_TOBAC_USE.

N-year risk	Females	Males
1	0.354%	0.697%
5	1.971%	4.435%
10	4.785%	10.632%
15	9.024%	19.49%
20	15.459%	32.185%

Relationships between endpoints

↥

Index endpoint: Z21_TOBAC_USE – Tobacco use

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Tobacco use

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints